MedPath

Pilot Study of CoolTXT for Non-Invasive Fat Reduction

Not Applicable
Completed
Conditions
Body Fat Disorder
Registration Number
NCT01517646
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

This study is being performed to reduce unwanted fat, in various body areas, using a new applicator and control unit for Zeltiq.

Detailed Description

The purpose of this study is to evaluate the safety and feasibility of a new product under development for non-invasive fat reduction. The new product delivers controlled cooling via a conformable surface applicator, rather than the existing vacuum applicator. A range of treatment parameters will be investigated. At the investigator's discretion, each treatment area may receive up to 3 treatments, spaced 2 - 8 weeks apart. The subjects will return for follow-up at 2 months and 4 months after final treatment. Therefore, the entire study period may last up to 8 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Efficacy Assessment through Ultrasound Measurements16 weeks post final treatment

The primary endpoint will be analyzed by percent reduction in fat layer thickness, as measured by ultrasound.

• Safety endpoint: incidence of device- or procedure-related adverse events. Acceptance criteria - zero incidences of UADEs.

Secondary Outcome Measures
NameTimeMethod
Outcome Measured by Photo Review and Subject Satisfaction Questionnaire16 weeks post final treatment

* Comparison of pre- and 16-week post final treatment photographs of the treatment area(s).

* Subject satisfaction as assessed by questionnaires administered at 16 weeks post final treatment.

Trial Locations

Locations (1)

Arbutus Laser Centre

🇨🇦

Vancouver, British Columbia, Canada

Arbutus Laser Centre
🇨🇦Vancouver, British Columbia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.